AIMS65 Score for Upper GI Bleeding Mortality
Predicts in-hospital mortality and need for ICU admission in upper GI bleeding. Simpler than Glasgow-Blatchford; uses 5 binary variables obtainable at triage.
Score interpretation
In-hospital mortality ~0.3%. Very low risk.
→ Safe for ward-level care. Early endoscopy within 24h. Consider same-day discharge after endoscopy in selected low-risk patients.
In-hospital mortality ~0.9%. Low risk.
→ Admit. Oral PPI. Urgent inpatient endoscopy within 24h.
In-hospital mortality ~6.4%.
→ Admit. IV PPI (omeprazole 80mg bolus then 8mg/h). Endoscopy within 12–24h. GI consult.
In-hospital mortality ~13.1%.
→ HDU/ICU. IV PPI infusion. Urgent endoscopy. Transfuse if Hb < 70 g/L. GI + surgical on call.
In-hospital mortality >20%. Very high risk.
→ ICU admission. Emergency endoscopy. Interventional radiology / surgical standby. Blood products. Early palliative involvement if appropriate.
Interpretation bands for the AIMS65. Apply clinical judgement and local guidance.
References
- Saltzman JR, et al. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 2011;74(6):1215–1224.
Related
Curated clinical cross-links plus same-class fallbacks.
- Vasopressin / Terlipressin · Vasopressin Analogue — Vasodilatory Shock / Variceal Bleeding
- Albumin solution · Plasma derivative / colloid
- Tranexamic Acid (Heavy Menstrual Bleeding) · Antifibrinolytic (Gynaecological Use)
- Human Albumin Solution (Burns) · Colloid Solution
- Human Albumin Solution (Surgical — Volume/Oncotic) · Plasma Protein Solution — Colloid
- Upper GI Bleeding · BSG Guidelines 2019; NICE NG141
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.